SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in West Palm Beach, FL.

Stablecoin Development Corp.

A sharp momentum-driven rally has fueled speculation about a low-float short squeeze, with traders also pointing to SDEVs SKY-token treasury exposure as a crypto-related draw. Bulls are focused on continued buying and scarce shares to borrow, while skeptics say the surge lacks a clear new business catalyst and warn of dilution or a sharp reversal.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Musks discussions with TSMC about its Terafab project have traders questioning whether Intel could lose part of the opportunity; no signed TSMC deal is established in the conversation. Bearish reactions focus on the risk of Intel being sidelined, while bulls argue TSMC could supplement Intels role amid strong chip demand, alongside heavy debate over volatile, options-driven trading.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Melius Researchs upgrade of Microsoft to Buy, citing its enterprise AI positioning and potential Azure acceleration, is fueling bullish discussion. Traders are also focused on whether the stock can break through persistent resistance, with some expecting a breakout and others frustrated by repeated rejections.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is drawing attention amid volatile software-sector trading and rotation between SaaS names and semiconductor stocks, with traders debating whether AI will disrupt established software firms or strengthen enterprise workflow platforms like NOW. Bulls point to its enterprise-AI opportunity and recent analyst optimism, while bears cite valuation, rising-rate sensitivity, and weak price action around key technical levels.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms multiyear patent cross-license agreement with Huawei, covering areas including AI, computing and networking, is drawing attention. Some traders view the deal as validation of Qualcomms technology and an expansion of its AI-related IP, while others argue the licensing arrangement could be unfavorable to Qualcomm.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Michael Caputos appointment to the Presidents Cancer Panel has fueled speculation that ImmunityBios Anktiva could gain broader access, though no such policy change is confirmed. Traders also debate whether the sharp, high-volume breakout reflects short covering and technical buying or anticipation of further news; some note the rally came without a new company announcement.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm is drawing attention on expectations that Metas Muse agent and broader agentic-AI workloads will lift demand for CPUs, alongside Arms move into data-center silicon with its AGI CPU. Traders are bullish on the AI infrastructure opportunity, while others argue the rally is stretched and Arms valuation may not be justified by near-term fundamentals.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs self-hosted deployment for its Bob AI coding platform, aimed at enterprises with strict data-control needs, is driving bullish attention, with strong Accenture consulting results also supporting optimism about enterprise spending. Some traders see the developments as a boost to IBMs AI story, while others question whether the product news can sustain the stocks gains.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons reported plan to move Nvidia AI chips into an outside-investor vehicle and lease them back has sparked debate over whether it is balance-sheet financing or a sign of risks around heavy AI spending and chip demand. Some traders view the move as a practical way to fund infrastructure while AWS demand grows, while others are wary of circular financing and frustrated by the stocks underperformance.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results and raised outlook, alongside Agentforce momentum and its Anthropic partnership, fueled optimism that AI could boost rather than displace established software providers. Traders remain divided: bulls see AI monetization and a recovery in SaaS, while skeptics question whether adoption will translate into durable revenue and point to the stocks volatile pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +200.00% and +7.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests

Key Points10,000 Common Stock shares were sold for a transaction value of $402,000 at an average price of around $40.24 per share on June 18, 2026...

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More...

Vericel (VCEL) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL

Conestoga Capital Advisors LLC grew its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the...

Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor

Vericel (NASDAQ:VCEL) held its 2026 annual meeting of shareholders on April 29 in a virtual format, with Chairman Dr. Robert Zerbe presiding. Zerbe said the meeting was conducted pursuant to Michigan law, the company's bylaws, and the notice distributed to shareholders. Sean Flynn, Vericel's corpora...

Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports...

Vericel (NASDAQ:VCEL) Shares Down 7.1% - Time to Sell?

Vericel (NASDAQ:VCEL) Trading Down 7.1% - What's Next...

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Vericel Corp

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$40.15
Prev Close	$39.44
Open	$40.01
Dividend Yield	0.00%
50-Day Moving Average	$42.14
Beta	1.15
Avg. Volume	503,303.75
PE Ratio	86.87

52-Week High	$49.32
52-Week Low	$28.95
Market Capitalization	$2.06B
EPS (Annual)	$0.3167
Price to Book	5.55
Revenue Per Employee	$694,118.09

Feed

News

Sentiment

Earnings

Fundamentals

Info

VCEL Fundamentals